Wade G W & Inc Abb Vie Inc. Transaction History

Wade G W & Inc

$3.08 Billion
Q4 2023

A detailed history of Wade G W & Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Wade G W & Inc holds 43,099 shares of ABBV stock, worth $7.21 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

43,099

Previous 40,680 5.95%

Holding current value

$7.21 Million

Previous $6.06 Million 10.14%

% of portfolio

0.22%

Previous 0.23%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$137.6 - $154.97 $332,854 - $374,872	2,419 Added 5.95%	43,099 $6.68 Million
Q3 2023 Nov 08, 2023	SELL	$133.59 - $154.65 $75,077 - $86,913	-562 Reduced 1.36%	40,680 $6.06 Million
Q2 2023 Aug 10, 2023	SELL	$132.51 - $164.9 $288,739 - $359,317	-2,179 Reduced 5.02%	41,242 $5.56 Million
Q1 2023 May 09, 2023	SELL	$144.61 - $166.54 $8,242 - $9,492	-57 Reduced 0.13%	43,421 $6.92 Million
Q4 2022 Feb 10, 2023	BUY	$138.31 - $165.87 $786,015 - $942,639	5,683 Added 15.04%	43,478 $7.03 Million

Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $149,778 - $171,785	-1,116 Reduced 2.87%	37,795 $5.07 Million
Q2 2022 Aug 09, 2022	BUY	$137.62 - $174.96 $38,808 - $49,338	282 Added 0.73%	38,911 $5.96 Million
Q1 2022 May 10, 2022	BUY	$131.98 - $163.75 $40,253 - $49,943	305 Added 0.8%	38,629 $6.26 Million
Q4 2021 Feb 09, 2022	BUY	$107.43 - $135.93 $250,634 - $317,124	2,333 Added 6.48%	38,324 $5.19 Million
Q3 2021 Nov 03, 2021	BUY	$106.4 - $120.78 $159,280 - $180,807	1,497 Added 4.34%	35,991 $3.88 Million
Q2 2021 Aug 12, 2021	SELL	$105.21 - $117.21 $122,254 - $136,198	-1,162 Reduced 3.26%	34,494 $3.89 Million
Q1 2021 May 05, 2021	BUY	$102.3 - $112.62 $1.27 Million - $1.4 Million	12,411 Added 53.39%	35,656 $3.86 Million
Q4 2020 Feb 03, 2021	BUY	$80.49 - $108.67 $719,822 - $971,835	8,943 Added 62.53%	23,245 $2.49 Million
Q3 2020 Nov 09, 2020	BUY	$85.91 - $100.83 $2,920 - $3,428	34 Added 0.24%	14,302 $1.25 Million
Q2 2020 Aug 07, 2020	BUY	$73.37 - $98.18 $77,845 - $104,168	1,061 Added 8.03%	14,268 $1.4 Million
Q1 2020 May 06, 2020	BUY	$64.5 - $97.79 $179,503 - $272,149	2,783 Added 26.7%	13,207 $1.01 Million
Q4 2019 Feb 07, 2020	BUY	$72.13 - $90.25 $50,274 - $62,904	697 Added 7.17%	10,424 $923,000
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $23,050 - $27,713	366 Added 3.91%	9,727 $736,000
Q2 2019 Aug 12, 2019	SELL	$65.7 - $83.98 $100,849 - $128,909	-1,535 Reduced 14.09%	9,361 $681,000
Q1 2019 May 09, 2019	SELL	$77.14 - $90.79 $244,996 - $288,349	-3,176 Reduced 22.57%	10,896 $878,000
Q4 2018 Feb 04, 2019	BUY	$77.85 - $96.01 $115,685 - $142,670	1,486 Added 11.81%	14,072 $1.3 Million
Q3 2018 Nov 07, 2018	BUY	$88.91 - $98.84 $332,612 - $369,760	3,741 Added 42.3%	12,586 $1.19 Million
Q1 2018 May 04, 2018	SELL	$92.01 - $123.21 $552 - $739	-6 Reduced 0.07%	8,845 $837,000
Q4 2017 Feb 13, 2018	SELL	$89.56 - $98.21 $2,149 - $2,357	-24 Reduced 0.27%	8,851 $856,000
Q3 2017 Nov 09, 2017	BUY	$69.85 - $89.22 $619,918 - $791,827	8,875	8,875 $789,000

Others Institutions Holding ABBV

# of Institutions

3,653

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $296B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wade G W & Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wade G W & Inc with notifications on news.

Account